D07.61
Carcinoma in situ of scrotum
Clinical Classification Guidelines
Medical Intelligence & Overview
Carcinoma in situ (CIS) of the scrotum is a localized abnormal growth of cells that has not yet invaded deeper tissues or spread to other parts of the body. As a precursor to invasive cancer, CIS of the scrotum is characterized by abnormal cell changes confined to the outer layer of the skin of the scrotum. Early detection and appropriate management are important to prevent progression to invasive malignancy. This condition is classified under ICD-10 code D07.61 and requires medical evaluation for accurate diagnosis and treatment planning.
Causes & Symptoms
Clinical Causes: Chronic exposure to carcinogenic substances such as soot, tar, or certain chemicals. Prolonged contact with occupational hazards, particularly in industries involving coal tar, paraffin, or asphalt. Poor personal hygiene or inadequate skin care in the scrotal area. History of pre-existing skin conditions or injuries that compromise skin integrity. Genetic or hereditary predispositions that increase susceptibility to skin abnormalities.
Key Symptoms: Presence of a persistent, small, raised lesion or patch on the scrotum. Lesion that may appear as a reddish or pigmented plaque with a rough surface. Occasional itching, irritation, or discomfort in the affected area. Lesions that do not heal or tend to recur despite treatment. Absence of significant pain in early stages, making early detection challenging.
Diagnostic & Treatment
Diagnosis Path: Perform a thorough physical exam of the scrotal skin to identify suspicious lesions. Obtain a skin biopsy to examine the tissue microscopically for abnormal cell changes indicative of CIS. Utilize dermoscopy or imaging techniques if necessary to assess lesion characteristics. Exclude invasive cancer via histopathological analysis, ensuring the abnormal cells are confined to the epithelium. Potentially perform additional tests if there is suspicion of spread or related conditions.
Treatment Protocols: Surgical excision of the lesion with clear margins to completely remove abnormal tissue. Topical chemotherapy creams containing agents like 5-fluorouracil or imiquimod applied directly to the lesion. Cryotherapy, where extreme cold is used to destroy cancerous cells. Photodynamic therapy, involving light-activated drugs to target abnormal cells. Regular follow-up examinations to monitor for recurrence or progression. In some cases, a combination of treatments may be utilized for optimal outcomes.
Clinical Advice & FAQs
Billing Guidance
Is D07.61 a billable ICD-10 code?
Yes, D07.61 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D07.61?
Clinical documentation must specify the nature of Carcinoma in situ of scrotum and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
